However, it is important to consider that, for the use of GnRH analogs in clinical practice, it is necessary to have an understanding of the actions of these molecules in breast tumors, such as the pharmacology of agonists on the breast tumor, defining in detail their potency, and the signaling pathways involved, as well as possible adverse effects, among others. Here, GNRH1 is linked to breast neoplasm.